Sarepta Therapeutics logo

Sarepta Therapeutics share price today

(SRPT)

Sarepta Therapeutics share price is $124.09 & ₹10,639.48 as on 3 Jan 2025, 2.30 'hrs' IST

$124.09

2.5

(2.06%)

Market is closed - opens 8 PM, 03 Jan 2025

View live Sarepta Therapeutics share price in Dollar and Rupees. Guide to invest in Sarepta Therapeutics from India. Also see the sentimental analysis on Indian investors investing in Sarepta Therapeutics. Get details on the Indian mutual funds that are investing in Sarepta Therapeutics. Get Analyst recommendations and forecasts along with all the Sarepta Therapeutics's financials.

Sarepta Therapeutics share price movements

  • Today's Low: $121.28
    Today's High: $126.84

    Day's Volatility :4.38%

  • 52 Weeks Low: $91.34
    52 Weeks High: $173.25

    52 Weeks Volatility :47.28%

Sarepta Therapeutics Returns

PeriodSarepta Therapeutics, Inc.Sector (Health Care)Index (Russel 2000)
3 Months
0.99%
-10.0%
0.0%
6 Months
-19.86%
-4.7%
0.0%
1 Year
28.97%
-0.9%
0.0%
3 Years
36.37%
-2.4%
-21.2%

Sarepta Therapeutics Key Statistics

in dollars & INR

Previous Close
$121.59
Open
$122.72
Today's High
$126.84
Today's Low
$121.28
Market Capitalization
$11.6B
Today's Volume
$374.7K
52 Week High
$173.25
52 Week Low
$91.3439
Revenue TTM
$1.6B
EBITDA
$119.7M
Earnings Per Share (EPS)
$1.54
PE Ratio
78.95
Profit Margin
7.43%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
12.27%

How to invest in Sarepta Therapeutics from India?

It is very easy for Indian residents to invest directly in Sarepta Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Sarepta Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Sarepta Therapeutics or SRPT on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Sarepta Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Sarepta Therapeutics shares which would translate to 0.007 fractional shares of Sarepta Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Sarepta Therapeutics, in just a few clicks!

Returns in Sarepta Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Sarepta Therapeutics investment value today

Current value as on today

₹1,34,593

Returns

₹34,593

(+34.59%)

Returns from Sarepta Therapeutics Stock

₹31,619 (+31.62%)

Dollar Returns

₹2,975 (+2.97%)

Indian investors sentiment towards Sarepta Therapeutics

-38%

Period: Oct 4, 2024 to Jan 2, 2025. Change in 30 Days versus previous period

Search volume for Sarepta Therapeutics on INDmoney from India has reduced in the last 30 days as on Jan 3, 2025. -38% less investors are searching Sarepta Therapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Sarepta Therapeutics

  • BlackRock Inc

    10.81%

  • Vanguard Group Inc

    9.39%

  • Capital Research & Mgmt Co - Division 3

    6.55%

  • HHG PLC

    4.56%

  • State Street Corp

    4.47%

  • Wellington Management Company LLP

    2.85%

Analyst Recommendation on Sarepta Therapeutics

Buy

    82%Buy

    17%Hold

    0%Sell

Based on 29 Wall street analysts offering stock ratings for Sarepta Therapeutics(by analysts ranked 0 to 5 stars)

Based on 29 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
24
25
25
Hold
5
5
5
Sell
0
0
0

Analyst Forecast on Sarepta Therapeutics

What analysts predicted

Upside of 49.86%

Current:

$124.09

Target:

$185.96

Insights on Sarepta Therapeutics

  • Price Movement

    In the last 3 years, SRPT stock has moved up by 35.0%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 362.93M → 467.17M (in $), with an average increase of 22.3% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, 6.46M → 33.61M (in $), with an average increase of 80.8% per quarter
  • SRPT vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 38.8% return, outperforming this stock by 3.8%

Sarepta Therapeutics Technicals Summary

Sell

Neutral

Buy

Sarepta Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Sarepta Therapeutics Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Sarepta Therapeutics, Inc.
-3.51%
-19.86%
28.97%
36.37%
-7.5%
Regeneron Pharmaceuticals, Inc.
-4.97%
-31.12%
-21.91%
15.48%
91.62%
Biontech Se
-1.42%
42.28%
6.01%
-49.15%
155.61%
Alnylam Pharmaceuticals, Inc.
-6.56%
-6.26%
22.36%
42.41%
102.91%
Vertex Pharmaceuticals Incorporated
-11.88%
-15.14%
-3.23%
81.51%
79.75%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Sarepta Therapeutics, Inc.
78.95
78.95
159.25
3.73
0.12
0.02
NA
12.79
Regeneron Pharmaceuticals, Inc.
17.61
17.61
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Sarepta Therapeutics, Inc.
Buy
$11.6B
-7.5%
78.95
7.43%
Regeneron Pharmaceuticals, Inc.
Buy
$78.3B
91.62%
17.61
33.61%
Biontech Se
Buy
$27.3B
155.61%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.4B
102.91%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$103.7B
79.75%
32.84
-4.51%

About Sarepta Therapeutics

sarepta therapeutics is a biopharmaceutical company focused on the discovery and development of unique rna-targeted therapeutics for the treatment of rare, infectious and other diseases. the company is primarily focused on rapidly advancing the development of its potentially disease-modifying dmd drug candidates, including its lead dmd product candidate, eteplirsen, designed to skip exon 51. sarepta is also developing therapeutics for the treatment of infectious diseases, such as drug-resistant bacteria and other rare human diseases. for more information, please visit us at www.sarepta.com.
Organization
Sarepta Therapeutics
Employees
1314
CEO
Mr. Douglas S. Ingram Esq.
Industry
Health Technology

Management People of Sarepta Therapeutics

NameTitle
Mr. Douglas S. Ingram Esq.
President, CEO & Director
Mr. Ian Michael Estepan
Executive VP & CFO
Mr. Bilal Arif
Executive VP & Chief Technical Operations Officer
Dr. Louise R. Rodino-Klapac Ph.D.
Executive VP, Chief Scientific Officer and Head of Research & Development
Mr. Ryan E. Brown J.D.
Executive VP, Chief General Counsel & Corporate Secretary
Ms. Francesca T. Nolan
Executive Director of Investor Relations and Corporate Communications
Ms. Alison Nasisi
Executive VP & Chief People Officer
Dr. Diane L. Berry Ph.D.
Executive VP and Chief of Global Policy & Advocacy Officer
Mr. Dallan Murray
Executive VP & Chief Customer Officer
Mr. Will Tilton
Senior VP, Head of Strategy & Chief of Staff

Important FAQs about investing in Sarepta Therapeutics from India :

What is Sarepta Therapeutics share price today?

Sarepta Therapeutics share price today stands at $124.09, Open: $122.72 ; Previous Close: $121.59 ; High: $126.84 ; Low: $121.28 ; 52 Week High: $173.25 ; 52 Week Low: $91.34. The stock opens at $122.72, after a previous close of $121.59. The stock reached a daily high of $126.84 and a low of $121.28, with a 52-week high of $173.25 and a 52-week low of $91.34.

Can Indians buy Sarepta Therapeutics shares?

Yes, Indians can invest in the Sarepta Therapeutics (SRPT) from India.

With INDmoney, you can buy Sarepta Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Sarepta Therapeutics at zero transaction cost.

How can I buy Sarepta Therapeutics shares from India?

It is very easy to buy Sarepta Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Sarepta Therapeutics be purchased?

Yes, you can buy fractional shares of Sarepta Therapeutics with INDmoney app.

What are the documents required to start investing in Sarepta Therapeutics stocks?

To start investing in Sarepta Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Sarepta Therapeutics

Today’s highest price of Sarepta Therapeutics (SRPT) is $126.84.

Today’s lowest price of Sarepta Therapeutics (SRPT) is $121.28.

What is today's market capitalisation of Sarepta Therapeutics

Today's market capitalisation of Sarepta Therapeutics SRPT is 11.6B

What is the 52 Week High and Low Range of Sarepta Therapeutics

  • 52 Week High

    $173.25

  • 52 Week Low

    $91.34

What are the historical returns of Sarepta Therapeutics?

  • 1 Month Returns

    -3.51%

  • 3 Months Returns

    -19.86%

  • 1 Year Returns

    28.97%

  • 5 Years Returns

    -7.5%

Who is the Chief Executive Officer (CEO) of Sarepta Therapeutics

Mr. Douglas S. Ingram Esq. is the current Chief Executive Officer (CEO) of Sarepta Therapeutics.